Gemcitabine + Carboplatin + Nivolumab Versus Gemcitabine + Oxaliplatin + Nivolumab in Cisplatin-ineligible Patients With Metastatic Urothelial Cancer
Clinical trial NCT03451331 · COMPLETED
Trial details
- NCT number
- NCT03451331
- Sponsor
- Matthew Galsky
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-10
- Primary completion
- 2023-06-07
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.